Back

The year in review: top trials in coronary interventions impacting guidelines and patient care - discussion

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: The year in review: top trials in coronary interventions impacting guidelines and patient care Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

4 More presentations in this session

Presentation thumbnail
Microaxial flow pump or standard care in infarct-related cardiogenic shock: the DanGer shock trial
Professor C. Hassager (Copenhagen, DK)
Slides Video
Presentation thumbnail
A placebo-controlled trial of percutaneous coronary intervention for stable angina: the ORBITA-2 trial
Doctor R. Al-Lamee (London, GB)
Slides Video
Presentation thumbnail
ILUMIEN IV: optical coherence tomography-guided vs. angiography-guided PCI
Doctor Z. Ali (Roslyn, US)
Slides Video
Presentation thumbnail
Paclitaxel-coated balloon vs. uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomised clinical trial
Doctor R. Yeh (Boston, US)
Slides Video

Access the full session

Session thumbnail
The year in review: top trials in coronary interventions impacting guidelines and patient care
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Session
The year in review: top trials in coronary interventions impacting guidelines and patient care
thumbnail
Congress Session
Ask the Trialists from Hot Line 4
thumbnail
Congress Presentation
A year in review: key trials in coronary and structural interventions shaping guidelines and patient care - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources